• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Clin Lab Anal . Correlations of disease severity and age with hematology parameter variations in patients with COVID-19 pre- and post-treatment

tetano

Editor, Senior Moderator
J Clin Lab Anal


. 2020 Nov 21;e23609.
doi: 10.1002/jcla.23609. Online ahead of print.
Correlations of disease severity and age with hematology parameter variations in patients with COVID-19 pre- and post-treatment


Juanying Liang[SUP] 1 [/SUP], Shaoyun Nong[SUP] 2 [/SUP], Liejun Jiang[SUP] 3 [/SUP], Xiaowei Chi[SUP] 4 [/SUP], Dewu Bi[SUP] 1 [/SUP], Jun Cao[SUP] 1 [/SUP], Lida Mo[SUP] 1 [/SUP], Xiaolu Luo[SUP] 1 [/SUP], Huayi Huang[SUP] 5 6 7 [/SUP]



Affiliations

Abstract

Background: For better understanding of the pathological changes of COVID-19, benefiting clinical management of the disease and the preparation for future waves of similar pandemics.
Methods: Hematology parameters from a total of 52 cases of COVID-19 admitted for treatment in a designated hospital were retrospectively analyzed. Data were analyzed by SPSS statistical software.
Results: Pre-treatment T-cell subsets, total lymphocytes, red blood cell distribution width (RDW), eosinophils, and basophils were significantly lower than that of post-treatment, while the inflammatory indexes neutrophils, neutrophil to lymphocyte ratio (NLR), and C-reactive protein (CRP) levels, as well as red blood cell (RBC) and hemoglobin, were significantly reduced after treatment. The T-cell subsets, total lymphocytes, and basophils in severely and critically ill patients were significantly lower than those in moderately ill patients. Neutrophils, NLR, eosinophils, procalcitonin (PCT), and CRP was significantly higher in severely and critically ill patients than in moderately ill patients. CD3+, CD8+, total lymphocytes, platelets, and basophils in patients older than 50 were lower than that of those younger than 50, while neutrophils, NLR, CRP, and RDW in patients older than 50 were higher than that of younger than 50. There was a positive correlation among prothrombin time (PT), alanine aminotransferase (ALT), and aspartate aminotransferase (AST) in severely and critically ill patients.
Conclusions: T-cell subsets, lymphocyte count, RDW, neutrophils, eosinophils, NLR, CRP, PT, ALT, and AST are important indicators in the management especially for severely and critically ill patients with COVID-19.

Keywords: C-reactive protein; Coronavirus Disease 2019; T-cell subsets; neutrophil/lymphocyte ratio; red blood cell distribution width.
 
Back
Top Bottom